Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Is it time to reconsider the Milan Criteria for selecting patients with hepatocellular carcinoma for deceased-donor liver transplantation?

Costentin CE, Bababekov YJ, Zhu AX, Yeh H.

Hepatology. 2018 Sep 19. doi: 10.1002/hep.30278. [Epub ahead of print] Review.

PMID:
30229978
2.

Ligand "noninnocence" in coordination complexes vs. kinetic, mechanistic, and selectivity issues in electrochemical catalysis.

Costentin C, Savéant JM, Tard C.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9104-9109. doi: 10.1073/pnas.1810255115. Epub 2018 Aug 24.

PMID:
30143579
3.

LBA-001Efficacy, tolerability and impact on quality of life of selective internal radiation therapy (with yttrium-90 resin microspheres) or sorafenib in patients with locally advanced hepatocellular carcinoma: The SARAH trial.

Bouattour M, Assenat E, Guiu B, Ilonca Alina D, Pageaux GP, Sibert A, Lebtahi R, Allaham W, Barraud H, Laurent V, Mathias E, Bronowicki JP, Tasu JP, Perdrisot R, Silvain C, Gerolami R, Mundler O, Seitz JF, Vidal V, Aubé C, Oberti F, Couturier O, Brenot-Rossi I, Raoul JL, Sarran A, Costentin C, Itti E, Luciani A, Adam R, Lewin M, Samuel D, Ronot M, Dinut A, Pereira H, Castera L, Chatellier G, Vilgrain V; SARAH Trial Group.

Ann Oncol. 2017 Jun 1;28(suppl_3). doi: 10.1093/annonc/mdx302. No abstract available.

PMID:
30052793
4.

Oxygen activation at a dicobalt centre of a dipyridylethane naphthyridine complex.

Brodsky CN, Passard G, Ullman AM, Jaramillo DE, Bloch ED, Huynh M, Gygi D, Costentin C, Nocera DG.

Dalton Trans. 2018 Aug 29;47(34):11903-11908. doi: 10.1039/c8dt01598h.

PMID:
29942938
5.

Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.

Costentin CE, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Letouzé E, Imbeaud S, Zucman-Rossi J, Audureau E, Roudot-Thoraval F, Nahon P; ANRS CO12 CirVir Group.

Gastroenterology. 2018 Aug;155(2):431-442.e10. doi: 10.1053/j.gastro.2018.04.027. Epub 2018 May 3.

PMID:
29729258
6.

Reply to: "Response to: Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma".

Chalaye J, Costentin CE, Luciani A, Nault JC.

J Hepatol. 2018 Aug;69(2):555-556. doi: 10.1016/j.jhep.2018.04.020. Epub 2018 Apr 30. No abstract available.

PMID:
29719212
7.

Properties of Site-Specifically Incorporated 3-Aminotyrosine in Proteins To Study Redox-Active Tyrosines: Escherichia coli Ribonucleotide Reductase as a Paradigm.

Lee W, Kasanmascheff M, Huynh M, Quartararo A, Costentin C, Bejenke I, Nocera DG, Bennati M, Tommos C, Stubbe J.

Biochemistry. 2018 Jun 19;57(24):3402-3415. doi: 10.1021/acs.biochem.8b00160. Epub 2018 Apr 17.

8.

Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study.

Costentin CE, Mourad A, Lahmek P, Causse X, Pariente A, Hagège H, Dobrin AS, Becker C, Marks B, Bader R, Condat B, Héluwaert F, Seitz JF, Lesgourgues B, Denis J, Deuffic-Burban S, Rosa I, Decaens T; CHANGH Study Group.

Cancer. 2018 May 1;124(9):1964-1972. doi: 10.1002/cncr.31215. Epub 2018 Mar 28.

PMID:
29589878
9.

Advanced Hepatocellular Carcinoma: Pretreatment Contrast-enhanced CT Texture Parameters as Predictive Biomarkers of Survival in Patients Treated with Sorafenib.

Mulé S, Thiefin G, Costentin C, Durot C, Rahmouni A, Luciani A, Hoeffel C.

Radiology. 2018 Aug;288(2):445-455. doi: 10.1148/radiol.2018171320. Epub 2018 Mar 27.

PMID:
29584597
10.

Hepatocellular Carcinoma With Portal Venous Invasion: Radiating New Hope?

Farsad K, Costentin CE, Zhu AX.

JAMA Oncol. 2018 May 1;4(5):669-670. doi: 10.1001/jamaoncol.2018.0007. No abstract available.

PMID:
29543953
11.

Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.

Chalaye J, Costentin CE, Luciani A, Amaddeo G, Ganne-Carrié N, Baranes L, Allaire M, Calderaro J, Azoulay D, Nahon P, Seror O, Mallat A, Soussan M, Duvoux C, Itti E, Nault JC.

J Hepatol. 2018 Aug;69(2):336-344. doi: 10.1016/j.jhep.2018.02.018. Epub 2018 Mar 6.

PMID:
29518452
12.

Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.

Ziol M, Poté N, Amaddeo G, Laurent A, Nault JC, Oberti F, Costentin C, Michalak S, Bouattour M, Francoz C, Pageaux GP, Ramos J, Decaens T, Luciani A, Guiu B, Vilgrain V, Aubé C, Derman J, Charpy C, Zucman-Rossi J, Barget N, Seror O, Ganne-Carrié N, Paradis V, Calderaro J.

Hepatology. 2018 Jul;68(1):103-112. doi: 10.1002/hep.29762. Epub 2018 May 9.

PMID:
29281854
13.

Hepatocellular Carcinoma with Macrovascular Invasion: Defining the Optimal Treatment Strategy.

Costentin CE, Ferrone CR, Arellano RS, Ganguli S, Hong TS, Zhu AX.

Liver Cancer. 2017 Nov;6(4):360-374. doi: 10.1159/000481315. Epub 2017 Oct 19. Review.

14.

Correction to: Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?

Roux M, Pigneur F, Baranes L, Calderaro J, Chiaradia M, Decaens T, Kastahian S, Charles-Nelson A, Tselikas L, Costentin C, Laurent A, Azoulay D, Mallat A, Rahmouni A, Luciani A.

Abdom Radiol (NY). 2018 Aug;43(8):2212. doi: 10.1007/s00261-017-1423-x.

PMID:
29230554
15.

Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?

Roux M, Pigneur F, Baranes L, Calderaro J, Chiaradia M, Decaens T, Kastahian S, Charles-Nelson A, Tselikas L, Costentin C, Laurent A, Azoulay D, Mallat A, Rahmouni A, Luciani A.

Abdom Radiol (NY). 2018 Jul;43(7):1670-1681. doi: 10.1007/s00261-017-1377-z. Erratum in: Abdom Radiol (NY). 2017 Dec 11;:.

PMID:
29110059
16.

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.

Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux GP, Sibert A, Bouattour M, Lebtahi R, Allaham W, Barraud H, Laurent V, Mathias E, Bronowicki JP, Tasu JP, Perdrisot R, Silvain C, Gerolami R, Mundler O, Seitz JF, Vidal V, Aubé C, Oberti F, Couturier O, Brenot-Rossi I, Raoul JL, Sarran A, Costentin C, Itti E, Luciani A, Adam R, Lewin M, Samuel D, Ronot M, Dinut A, Castera L, Chatellier G; SARAH Trial Group.

Lancet Oncol. 2017 Dec;18(12):1624-1636. doi: 10.1016/S1470-2045(17)30683-6. Epub 2017 Oct 26.

PMID:
29107679
17.

Multielectron, multisubstrate molecular catalysis of electrochemical reactions: Formal kinetic analysis in the total catalysis regime.

Costentin C, Nocera DG, Brodsky CN.

Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11303-11308. doi: 10.1073/pnas.1711129114. Epub 2017 Oct 9.

18.

Catalysis and Inhibition in the Electrochemical Reduction of CO2 on Platinum in the Presence of Protonated Pyridine. New Insights into Mechanisms and Products.

Dridi H, Comminges C, Morais C, Meledje JC, Kokoh KB, Costentin C, Savéant JM.

J Am Chem Soc. 2017 Oct 4;139(39):13922-13928. doi: 10.1021/jacs.7b08028. Epub 2017 Sep 25.

PMID:
28892610
19.

Self-healing catalysis in water.

Costentin C, Nocera DG.

Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13380-13384. doi: 10.1073/pnas.1711836114. Epub 2017 Sep 5.

20.

Nanodiffusion in electrocatalytic films.

Costentin C, Di Giovanni C, Giraud M, Savéant JM, Tard C.

Nat Mater. 2017 Oct;16(10):1016-1021. doi: 10.1038/nmat4968. Epub 2017 Aug 21.

PMID:
28825730
21.

[Care pathway of patients with hepatocellular carcinoma in France: State of play in 2017].

Costentin C, Ganne-Carrié N, Rousseau B, Gérolami R, Barbare JC.

Bull Cancer. 2017 Sep;104(9):752-761. doi: 10.1016/j.bulcan.2017.06.008. Epub 2017 Jul 24. Review. French.

PMID:
28751065
22.

One year of baclofen in 100 patients with or without cirrhosis: a French real-life experience.

Barrault C, Lison H, Roudot-Thoraval F, Garioud A, Costentin C, Béhar V, Medmoun M, Pulwermacher G, Hagège H, Cadranel JF.

Eur J Gastroenterol Hepatol. 2017 Oct;29(10):1155-1160. doi: 10.1097/MEG.0000000000000922.

PMID:
28727631
23.

Cyclic voltammetry modeling of proton transport effects on redox charge storage in conductive materials: application to a TiO2 mesoporous film.

Kim YS, Balland V, Limoges B, Costentin C.

Phys Chem Chem Phys. 2017 Jul 21;19(27):17944-17951. doi: 10.1039/c7cp02810e. Epub 2017 Jun 30.

PMID:
28664973
24.

Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis.

Costentin CE, Decaens T, Laurent A, Nault JC, Paule B, Letoublon C, Luciani A, Calderaro J, Adam R, Bricault I, Amaddeo G, Cherqui D, Mallat A, Samuel D, Duvoux C, Ganne-Carrié N, Roudot-Thoraval F, Vibert E.

Liver Int. 2017 Dec;37(12):1869-1876. doi: 10.1111/liv.13491. Epub 2017 Jul 13.

PMID:
28609020
25.

Heterogeneous Molecular Catalysis of Electrochemical Reactions: Volcano Plots and Catalytic Tafel Plots.

Costentin C, Savéant JM.

ACS Appl Mater Interfaces. 2017 Jun 14;9(23):19894-19899. doi: 10.1021/acsami.7b04349. Epub 2017 Jun 2.

PMID:
28530798
26.

Simultaneous analysis of regorafenib and sorafenib and three of their metabolites in human plasma using LC-MS/MS.

Allard M, Khoudour N, Rousseau B, Joly C, Costentin C, Blanchet B, Tournigand C, Hulin A.

J Pharm Biomed Anal. 2017 Aug 5;142:42-48. doi: 10.1016/j.jpba.2017.04.053. Epub 2017 May 1.

PMID:
28494338
27.

Homogeneous Molecular Catalysis of Electrochemical Reactions: Catalyst Benchmarking and Optimization Strategies.

Costentin C, Savéant JM.

J Am Chem Soc. 2017 Jun 21;139(24):8245-8250. doi: 10.1021/jacs.7b02879. Epub 2017 Jun 13.

PMID:
28460524
28.

Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.

Menahem B, Lubrano J, Duvoux C, Mulliri A, Alves A, Costentin C, Mallat A, Launoy G, Laurent A.

Liver Transpl. 2017 Jun;23(6):836-844. doi: 10.1002/lt.24758. Review.

29.

Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic models.

Costentin CE, Amaddeo G, Decaens T, Boudjema K, Bachellier P, Muscari F, Salamé E, Bernard PH, Francoz C, Dharancy S, Vanlemmens C, Radenne S, Dumortier J, Hilleret MN, Chazouillères O, Pageaux GP, Calderaro J, Laurent A, Roudot-Thoraval F, Duvoux C; Liver Transplantation French Study Group.

Liver Int. 2017 May;37(5):717-726. doi: 10.1111/liv.13388. Epub 2017 Mar 24.

PMID:
28199760
30.

How Do Pseudocapacitors Store Energy? Theoretical Analysis and Experimental Illustration.

Costentin C, Porter TR, Savéant JM.

ACS Appl Mater Interfaces. 2017 Mar 15;9(10):8649-8658. doi: 10.1021/acsami.6b14100. Epub 2017 Mar 1.

PMID:
28195702
31.

Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.

Cadier B, Bulsei J, Nahon P, Seror O, Laurent A, Rosa I, Layese R, Costentin C, Cagnot C, Durand-Zaleski I, Chevreul K; ANRS CO12 CirVir and CHANGH groups.

Hepatology. 2017 Apr;65(4):1237-1248. doi: 10.1002/hep.28961. Epub 2017 Feb 8.

PMID:
28176349
32.

[Hepatocellular carcinoma surveillance].

Costentin C.

Presse Med. 2017 Apr;46(4):381-385. doi: 10.1016/j.lpm.2016.11.006. Epub 2017 Jan 9. French.

PMID:
28081946
33.

Through-Space Charge Interaction Substituent Effects in Molecular Catalysis Leading to the Design of the Most Efficient Catalyst of CO2-to-CO Electrochemical Conversion.

Azcarate I, Costentin C, Robert M, Savéant JM.

J Am Chem Soc. 2016 Dec 28;138(51):16639-16644. doi: 10.1021/jacs.6b07014. Epub 2016 Dec 15.

PMID:
27976580
34.

Catalysis at the nanoscale may change selectivity.

Costentin C, Savéant JM.

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11756-11758. Epub 2016 Sep 29.

35.

Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors.

Tselikas L, Pigneur F, Roux M, Baranes L, Costentin C, Roche V, Calderaro J, Herin E, Laurent A, Zafrani E, Azoulay D, Mallat A, Rahmouni A, Luciani A.

Abdom Radiol (NY). 2017 Mar;42(3):825-832. doi: 10.1007/s00261-016-0921-6.

PMID:
27704147
36.

Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation.

de'Angelis N, Landi F, Nencioni M, Palen A, Lahat E, Salloum C, Compagnon P, Lim C, Costentin C, Calderaro J, Luciani A, Feray C, Azoulay D.

Prog Transplant. 2016 Dec;26(4):348-355. doi: 10.1177/1526924816664083. Epub 2016 Sep 20.

PMID:
27555074
37.

Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features.

Calderaro J, Rousseau B, Amaddeo G, Mercey M, Charpy C, Costentin C, Luciani A, Zafrani ES, Laurent A, Azoulay D, Lafdil F, Pawlotsky JM.

Hepatology. 2016 Dec;64(6):2038-2046. doi: 10.1002/hep.28710. Epub 2016 Aug 9.

PMID:
27359084
38.

Efficient electrolyzer for CO2 splitting in neutral water using earth-abundant materials.

Tatin A, Comminges C, Kokoh B, Costentin C, Robert M, Savéant JM.

Proc Natl Acad Sci U S A. 2016 May 17;113(20):5526-9. doi: 10.1073/pnas.1604628113. Epub 2016 May 2.

39.

Conduction and Reactivity in Heterogeneous-Molecular Catalysis: New Insights in Water Oxidation Catalysis by Phosphate Cobalt Oxide Films.

Costentin C, Porter TR, Savéant JM.

J Am Chem Soc. 2016 May 4;138(17):5615-22. doi: 10.1021/jacs.6b00737. Epub 2016 Apr 25.

PMID:
26981886
40.

Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation.

Boussouar S, Itti E, Lin SJ, Decaens T, Evangelista E, Chiaradia M, Chalaye J, Baranes L, Calderaro J, Laurent A, Pigneur F, Duvoux C, Azoulay D, Costentin C, Rahmouni A, Luciani A.

Cancer Imaging. 2016 Feb 16;16:4. doi: 10.1186/s40644-016-0062-8.

41.

Current Issues in Molecular Catalysis Illustrated by Iron Porphyrins as Catalysts of the CO2-to-CO Electrochemical Conversion.

Costentin C, Robert M, Savéant JM.

Acc Chem Res. 2015 Dec 15;48(12):2996-3006. doi: 10.1021/acs.accounts.5b00262. Epub 2015 Nov 12.

PMID:
26559053
42.

Molecular Catalysis of O2 Reduction by Iron Porphyrins in Water: Heterogeneous versus Homogeneous Pathways.

Costentin C, Dridi H, Savéant JM.

J Am Chem Soc. 2015 Oct 28;137(42):13535-44. doi: 10.1021/jacs.5b06834. Epub 2015 Oct 16.

PMID:
26414306
43.

Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors.

Nault JC, Pigneur F, Nelson AC, Costentin C, Tselikas L, Katsahian S, Diao G, Laurent A, Mallat A, Duvoux C, Luciani A, Decaens T.

Dig Liver Dis. 2015 Oct;47(10):869-76. doi: 10.1016/j.dld.2015.07.001. Epub 2015 Jul 10.

PMID:
26211871
44.

Cyclic voltammetry of fast conducting electrocatalytic films.

Costentin C, Savéant JM.

Phys Chem Chem Phys. 2015 Jul 15;17(29):19350-9. doi: 10.1039/c5cp02825f.

PMID:
26140372
45.

Efficient and selective molecular catalyst for the CO2-to-CO electrochemical conversion in water.

Costentin C, Robert M, Savéant JM, Tatin A.

Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):6882-6. doi: 10.1073/pnas.1507063112. Epub 2015 May 18.

46.

Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.

Roux M, Pigneur F, Calderaro J, Baranes L, Chiaradia M, Tselikas L, Decaens T, Costentin C, Laurent A, Azoulay D, Mallat A, Zafrani ES, Rahmouni A, Luciani A.

J Magn Reson Imaging. 2015 Nov;42(5):1249-58. doi: 10.1002/jmri.24897. Epub 2015 Apr 6.

PMID:
25851028
47.

Unraveling the charge transfer/electron transport in mesoporous semiconductive TiO2 films by voltabsorptometry.

Renault C, Nicole L, Sanchez C, Costentin C, Balland V, Limoges B.

Phys Chem Chem Phys. 2015 Apr 28;17(16):10592-607. doi: 10.1039/c5cp00023h.

PMID:
25804293
48.

Benchmarking of homogeneous electrocatalysts: overpotential, turnover frequency, limiting turnover number.

Costentin C, Passard G, Savéant JM.

J Am Chem Soc. 2015 Apr 29;137(16):5461-7. doi: 10.1021/jacs.5b00914. Epub 2015 Apr 21.

PMID:
25757058
49.

Ultraefficient homogeneous catalyst for the CO2-to-CO electrochemical conversion.

Costentin C, Passard G, Robert M, Savéant JM.

Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):14990-4. doi: 10.1073/pnas.1416697111. Epub 2014 Oct 6.

50.

Molecular catalysis of H2 evolution: diagnosing heterolytic versus homolytic pathways.

Costentin C, Dridi H, Savéant JM.

J Am Chem Soc. 2014 Oct 1;136(39):13727-34. doi: 10.1021/ja505845t. Epub 2014 Sep 19.

PMID:
25190347

Supplemental Content

Loading ...
Support Center